Breakthrough in Immunotherapy for Brain Cancer
Summary: Researchers unveiled a new combination immunotherapy that significantly boosts the immune response in patients with malignant gliomas. By integrating a personalized dendritic cell vaccine with poly-ICLC, an immune-boosting agent, the therapy has …